Persuasive Health Communication Intervention for HIV/HCV
A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive heal
| Condition(s) | Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive health communication intervention (PHCI) increases acceptance of testing among adult ED patients who either currently, formerly or never injected drugs and initially declined HIV/HCV screening. The research team will conduct a randomized, controlled trial (RCT) at EDs within the Mount Sinai Health System to compare the efficacy of the PHCI when delivered by a video vs. an HIV/HCV counselor. Patients who initially declined HIV/HCV screening will be stratified by injection-drug use |
| Who can participate | Inclusion Criteria: * ≥18 years-old * Speak English or Spanish, and able to provide informed consent for study participation * Not HIV AND HCV infected/Antibody+ (per EHR review and patient report) * Not already participating in a HIV or HCV study (e.g., HIV PrEP, HIV vaccine) * Not tested for HIV OR HCV within the past 12 months (per EHR review and patient report) Exclusion Criteria: * \<18 years old * Unable to speak Spanish or English * HIV or HCV positive * Currently enrolled in another HIV or HCV research study * Has tested for HIV or HCV in the past 12 months |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | University of South Florida |
| Locations | New York, New York, United States |
| Start date | 2023-12-04 |
| NCT ID | NCT05968573 |
| Official listing | https://clinicaltrials.gov/study/NCT05968573 |